Get it on Google Play

Junshi Biosciences receives FDA approval for NSCLC drug trial

October 16, 2025 8:23 PM EDT Send to a Friend
Shanghai Junshi Biosciences Co., Ltd (HKEX: 1877; SSE: 688180) announced that the U.S. Food and Drug Administration has approved its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login